Home

אווז נשא לנשוך sedermera fondkommission spotlight לנקות תוף מים

Growth doesn't have to be complicated
Growth doesn't have to be complicated

Interview with, Frederik Rahl, from MVA-member, Spotlight Group, about IPO  in Sweden for Danish life science companies - MVA
Interview with, Frederik Rahl, from MVA-member, Spotlight Group, about IPO in Sweden for Danish life science companies - MVA

SPOTLIGHT GROUP AB (PUBL) : SPGR Stock Price | SE0014704763 | MarketScreener
SPOTLIGHT GROUP AB (PUBL) : SPGR Stock Price | SE0014704763 | MarketScreener

Sedermera Fondkommission agerar finansiell rådgivare till FluoGuide A/S  inför planerad publik nyemission och notering på Spotlight Stock Market -  IPO.se
Sedermera Fondkommission agerar finansiell rådgivare till FluoGuide A/S inför planerad publik nyemission och notering på Spotlight Stock Market - IPO.se

Correction: First day of trading in Polymer Factory's shares and warrants  at Spotlight Stock Market
Correction: First day of trading in Polymer Factory's shares and warrants at Spotlight Stock Market

Spotlight Group i Malmö vill hjälpa fler danska bolag att börsnotera sig i  Sverige: ”En börsnotering ger långsiktig tillgång till tillväxtkapital” –  News Øresund Sverige
Spotlight Group i Malmö vill hjälpa fler danska bolag att börsnotera sig i Sverige: ”En börsnotering ger långsiktig tillgång till tillväxtkapital” – News Øresund Sverige

Spotlight Stock Market | LinkedIn
Spotlight Stock Market | LinkedIn

Invitation to subscribe for shares in STENOCARE A/S prior to its planned  listing on Spotlight Stock Market
Invitation to subscribe for shares in STENOCARE A/S prior to its planned listing on Spotlight Stock Market

Curasigt on Spotlight Stock Market. Sedermera Fondkommission on Vimeo
Curasigt on Spotlight Stock Market. Sedermera Fondkommission on Vimeo

Press Release 2018-08-06 Scandion Oncology A/S signs agreement with Sedermera  Fondkommission AB regarding an Initial Public Offe
Press Release 2018-08-06 Scandion Oncology A/S signs agreement with Sedermera Fondkommission AB regarding an Initial Public Offe

First day of trading in Curasight's shares and warrants at Spotlight Stock  Market
First day of trading in Curasight's shares and warrants at Spotlight Stock Market

The subscription period begins in Genetic Analysis AS issue of units prior  to planned listing on Spotlight Stock Market
The subscription period begins in Genetic Analysis AS issue of units prior to planned listing on Spotlight Stock Market

KID Document
KID Document

Sedermera Fondkommission | LinkedIn
Sedermera Fondkommission | LinkedIn

Agents - IPOhub
Agents - IPOhub

Ectin Research AB utser Sedermera Fondkommission till finansiell rådgivare  i avsikt att notera bolaget på Spotlight Stock Market | Ectin
Ectin Research AB utser Sedermera Fondkommission till finansiell rådgivare i avsikt att notera bolaget på Spotlight Stock Market | Ectin

Dear holder of Swedish Depository Receipts in Beowulf Mining plc,
Dear holder of Swedish Depository Receipts in Beowulf Mining plc,

SynAct Pharma announces that the exercise period for warrants of the TO 2  series will start on July 1, 2020
SynAct Pharma announces that the exercise period for warrants of the TO 2 series will start on July 1, 2020

Spotlight Group AB | shark communication
Spotlight Group AB | shark communication

Spotlight Groups nya dotterbolag får grönt ljus av FI | Realtid
Spotlight Groups nya dotterbolag får grönt ljus av FI | Realtid

Invitation to subscribe for shares in Odinwell prior to listing at Spotlight  Stock Market Advertisement
Invitation to subscribe for shares in Odinwell prior to listing at Spotlight Stock Market Advertisement

INVITATION TO SUBSCRIBE FOR UNITS IN Genetic Analysis AS
INVITATION TO SUBSCRIBE FOR UNITS IN Genetic Analysis AS

Final registration of ODI Pharma's new share issue completed
Final registration of ODI Pharma's new share issue completed

History – Spotlight Group
History – Spotlight Group

Reminder to exercise Initiator Pharma A/S series TO 1 warrants
Reminder to exercise Initiator Pharma A/S series TO 1 warrants

OmniCar decides on rights issue for accelerated growth and advanced  profitability
OmniCar decides on rights issue for accelerated growth and advanced profitability